XML 19 R2.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2018
Dec. 31, 2017
CURRENT ASSETS    
Cash $ 186,204 $ 1,370,711
Research and development tax credit receivable 592,215 106,866
Other tax receivable 37,382 111,618
Joint development cost receivable 17,989 109,124
Prepaid expenses 15,552 42,647
Prepaid expenses - related party   158,504
TOTAL CURRENT ASSETS 849,342 1,899,470
Acquired in-process research and development intangible assets 16,514,000 16,514,000
TOTAL ASSETS 17,363,342 18,413,470
CURRENT LIABILITIES    
Accounts payable and accrued liabilities 814,746 126,257
Accounts payable and accrued liabilities - related parties 9,020 183,460
TOTAL LIABILITIES 823,766 309,717
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY    
Preferred stock, $0.001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding
Common stock, $0.001 par value, 200,000,000 shares authorized, 8,719,441 and 8,319,441 shares issued and outstanding, respectively 8,719 8,319
Additional paid-in capital 25,446,196 19,171,237
Common stock issuable 4,676,000 50,000
Accumulated other comprehensive income (loss) 6,529 32,042
Accumulated deficit (13,597,868) (1,157,845)
TOTAL STOCKHOLDERS' EQUITY 16,539,576 18,103,753
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 17,363,342 $ 18,413,470